GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF) » Definitions » Cyclically Adjusted PB Ratio

TKPHF (Takeda Pharmaceutical Co) Cyclically Adjusted PB Ratio : 1.02 (As of May. 31, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2025-05-31), Takeda Pharmaceutical Co's current share price is $26.30. Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $25.78. Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.02.

The historical rank and industry rank for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TKPHF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.03   Med: 1.35   Max: 2.42
Current: 1.17

During the past years, Takeda Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 2.42. The lowest was 1.03. And the median was 1.35.

TKPHF's Cyclically Adjusted PB Ratio is ranked better than
68.52% of 683 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs TKPHF: 1.17

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2025 was $29.566. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $25.78 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.40 1.19 1.37 1.24 1.22

Takeda Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 1.21 1.17 1.17 1.22

Competitive Comparison of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


;
;

Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=26.30/25.78
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Takeda Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=29.566/111.1000*111.1000
=29.566

Current CPI (Mar. 2025) = 111.1000.

Takeda Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 22.267 98.400 25.141
201509 22.440 98.500 25.310
201512 21.949 98.100 24.858
201603 22.023 97.900 24.992
201606 21.909 98.100 24.812
201609 22.807 98.000 25.856
201612 21.799 98.400 24.612
201703 21.484 98.100 24.331
201706 23.254 98.500 26.229
201709 24.102 98.800 27.103
201712 23.955 99.400 26.775
201803 24.107 99.200 26.999
201806 23.763 99.200 26.614
201809 24.757 99.900 27.533
201812 23.256 99.700 25.915
201903 29.987 99.700 33.416
201906 28.986 99.800 32.268
201909 29.046 100.100 32.238
201912 28.667 100.500 31.691
202003 28.163 100.300 31.196
202006 27.872 99.900 30.997
202009 28.244 99.900 31.410
202012 28.566 99.300 31.961
202103 30.441 99.900 33.854
202106 30.328 99.500 33.864
202109 30.727 100.100 34.104
202112 30.071 100.100 33.376
202203 30.730 101.100 33.770
202206 30.499 101.800 33.285
202209 30.138 103.100 32.477
202212 29.448 104.100 31.428
202303 30.580 104.400 32.543
202306 31.495 105.200 33.261
202309 30.482 106.200 31.888
202312 29.846 106.800 31.048
202403 30.941 107.200 32.067
202406 31.484 108.200 32.328
202409 30.541 108.900 31.158
202412 30.425 110.700 30.535
202503 29.566 111.100 29.566

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Takeda Pharmaceutical Co  (OTCPK:TKPHF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.